Skip to content

Examination for the acquisition of the facility criterion of laparoscopic surgery for renal malignant tumor (using supportive equipment for endoscopic surgery)

Examination for the acquisition of the facility criterion of laparoscopic surgery for renal malignant tumor (using supportive equipment for endoscopic surgery) - Examination for the acquisition of the facility criterion of Da Vinci partial nephrectomy for renal cell carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022146
Enrollment
10
Registered
2016-05-02
Start date
2016-05-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal cell carcinoma

Interventions

After the surgery, we follow-up 4 weeks.

Sponsors

Asahikawa Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with renal cell carcinoma cT1a, cN0, cM0. Patients obtained the consent in writing.

Exclusion criteria

Exclusion criteria: Patients with a previous treatment of ipsilateral partial nephrectomy. Patients with severe heart or respiratory failure. Patients with severe renal dysfunction. Patients who physician has determined to be ineligible.

Design outcomes

Primary

MeasureTime frame
radical resection renal function

Secondary

MeasureTime frame
ischemic time estimated blood loss console time operating time complication

Countries

Japan

Contacts

Public ContactGaku Tamaki

Asahikawa Medical College Renal and Urologic Surgery

gtamajp@asahikawa-med.ac.jp0166-68-2533

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026